Niraj S Patel1, Iliana Doycheva2, Michael R Peterson3, Jonathan Hooker4, Tatiana Kisselva5, Bernd Schnabl2, Ekihiro Seki6, Claude B Sirlin4, Rohit Loomba7. 1. Division of Internal Medicine, Department of Medicine, University of California San Diego Health System, La Jolla, California. 2. Division of Gastroenterology, Department of Medicine, University of California San Diego Health System, La Jolla, California. 3. Department of Pathology, University of California San Diego Health System, La Jolla, California. 4. Liver Imaging Group, Department of Radiology, University of California San Diego Health System, La Jolla, California. 5. Department of Surgery, University of California San Diego Health System, La Jolla, California. 6. Division of Gastroenterology, Department of Medicine, University of California San Diego Health System, La Jolla, California; Department of Surgery, University of California San Diego Health System, La Jolla, California. 7. Division of Gastroenterology, Department of Medicine, University of California San Diego Health System, La Jolla, California; Division of Epidemiology, Department of Family and Preventive Medicine, University of California San Diego Health System, La Jolla, California. Electronic address: roloomba@ucsd.edu.
Abstract
BACKGROUND & AIMS: Little is known about how weight loss affects magnetic resonance imaging (MRI) of liver fat and volume or liver histology in patients with nonalcoholic steatohepatitis (NASH). We measured changes in liver fat and liver volume associated with weight loss by using an advanced MRI method. METHODS: We analyzed data collected from a previous randomized controlled trial in which 43 adult patients with biopsy-proven NASH underwent clinical evaluation, biochemical tests, and MRI and liver biopsy analyses at the start of the study and after 24 weeks. We compared data between patients who did and did not have at least 5% decrease in body mass index (BMI) during the study period. RESULTS: Ten of 43 patients had at least a 5% decrease in BMI during the study period. These patients had a significant decrease in liver fat, which was based on MRI proton density fat fraction estimates (18.3% ± 7.6% to 13.6% ± 13.6%, P = .03), a relative 25.5% reduction. They also had a significant decrease in liver volume (5.3%). However, no significant changes in levels of alanine aminotransferase or aspartate aminotransferase were observed with weight loss. Thirty-three patients without at least 5% decrease in BMI had insignificant increases in estimated liver fat fraction and liver volume. CONCLUSIONS: A reduction in BMI of at least 5% is associated with significant decrease in liver fat and volume in patients with biopsy-proven NASH. These data should be considered in assessing effect size in studies of patients with nonalcoholic fatty liver disease or obesity that use MRI-estimated liver fat and volume as end points.
RCT Entities:
BACKGROUND & AIMS: Little is known about how weight loss affects magnetic resonance imaging (MRI) of liver fat and volume or liver histology in patients with nonalcoholic steatohepatitis (NASH). We measured changes in liver fat and liver volume associated with weight loss by using an advanced MRI method. METHODS: We analyzed data collected from a previous randomized controlled trial in which 43 adult patients with biopsy-proven NASH underwent clinical evaluation, biochemical tests, and MRI and liver biopsy analyses at the start of the study and after 24 weeks. We compared data between patients who did and did not have at least 5% decrease in body mass index (BMI) during the study period. RESULTS: Ten of 43 patients had at least a 5% decrease in BMI during the study period. These patients had a significant decrease in liver fat, which was based on MRI proton density fat fraction estimates (18.3% ± 7.6% to 13.6% ± 13.6%, P = .03), a relative 25.5% reduction. They also had a significant decrease in liver volume (5.3%). However, no significant changes in levels of alanine aminotransferase or aspartate aminotransferase were observed with weight loss. Thirty-three patients without at least 5% decrease in BMI had insignificant increases in estimated liver fat fraction and liver volume. CONCLUSIONS: A reduction in BMI of at least 5% is associated with significant decrease in liver fat and volume in patients with biopsy-proven NASH. These data should be considered in assessing effect size in studies of patients with nonalcoholic fatty liver disease or obesity that use MRI-estimated liver fat and volume as end points.
Authors: S Bellentani; G Saccoccio; F Masutti; L S Crocè; G Brandi; F Sasso; G Cristanini; C Tiribelli Journal: Ann Intern Med Date: 2000-01-18 Impact factor: 25.391
Authors: Rohit Loomba; Maria Abraham; Aynur Unalp; Laura Wilson; Joel Lavine; Ed Doo; Nathan M Bass Journal: Hepatology Date: 2012-07-26 Impact factor: 17.425
Authors: Mariana Lazo; Steven F Solga; Alena Horska; Susanne Bonekamp; Anna Mae Diehl; Frederick L Brancati; Lynne E Wagenknecht; F Xavier Pi-Sunyer; Steven E Kahn; Jeanne M Clark Journal: Diabetes Care Date: 2010-07-27 Impact factor: 19.112
Authors: Mazen Noureddin; Katherine P Yates; Ivana A Vaughn; Brent A Neuschwander-Tetri; Arun J Sanyal; Arthur McCullough; Raphael Merriman; Bilal Hameed; Edward Doo; David E Kleiner; Cynthia Behling; Rohit Loomba Journal: Hepatology Date: 2013-10-02 Impact factor: 17.425
Authors: Catherine D G Hines; Huanzhou Yu; Ann Shimakawa; Charles A McKenzie; Jean H Brittain; Scott B Reeder Journal: J Magn Reson Imaging Date: 2009-11 Impact factor: 4.813
Authors: Neeraj Bhala; Paul Angulo; David van der Poorten; Eric Lee; Jason M Hui; Giorgio Saracco; Leon A Adams; Phunchai Charatcharoenwitthaya; Joanne H Topping; Elisabetta Bugianesi; Christopher P Day; Jacob George Journal: Hepatology Date: 2011-08-09 Impact factor: 17.425
Authors: Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner Journal: Gastroenterology Date: 2015-08-20 Impact factor: 22.682
Authors: Diego Hernando; Samir D Sharma; Mounes Aliyari Ghasabeh; Bret D Alvis; Sandeep S Arora; Gavin Hamilton; Li Pan; Jean M Shaffer; Keitaro Sofue; Nikolaus M Szeverenyi; E Brian Welch; Qing Yuan; Mustafa R Bashir; Ihab R Kamel; Mark J Rice; Claude B Sirlin; Takeshi Yokoo; Scott B Reeder Journal: Magn Reson Med Date: 2016-04-15 Impact factor: 4.668
Authors: Adrija Mamidipalli; Kathryn J Fowler; Gavin Hamilton; Tanya Wolfson; Yesenia Covarrubias; Calvin Tran; Soudabeh Fazeli; Curtis N Wiens; Alan McMillan; Nathan S Artz; Luke M Funk; Guilherme M Campos; Jacob A Greenberg; Anthony Gamst; Michael S Middleton; Jeffrey B Schwimmer; Scott B Reeder; Claude B Sirlin Journal: Eur Radiol Date: 2020-04-21 Impact factor: 5.315
Authors: Ran B Luo; Toshiaki Suzuki; Jonathan C Hooker; Yesenia Covarrubias; Alexandra Schlein; Shanglei Liu; Jeffrey B Schwimmer; Scott B Reeder; Luke M Funk; Jacob A Greenberg; Guilherme M Campos; Bryan J Sandler; Santiago Horgan; Claude B Sirlin; Garth R Jacobsen Journal: Surg Endosc Date: 2017-12-07 Impact factor: 4.584